IGXT =MC $34 M--FDA DECISION for Migraine Drug & Launch of Cannabis Products both expected during this Quarter !!!! Stock could run to $1 ahead of the FDA decision .GL
Intelgenx (IGXT)
Market Cap $34 M Price 0.36
Cannabis-Infused VersaFilm® Remains on Track for Commercial Launch in Q1-2020
IntelGenx Continues to Make Preparations Ahead of RIZAPORT® PDUFA Goal Date of March 26, 2020
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.